Peter Ordentlich Selected Research

Peter Ordentlich Research Topics

Disease

12	Neoplasms (Cancer) 01/2020 - 09/2008
5	Breast Neoplasms (Breast Cancer) 08/2017 - 11/2009
4	Carcinoma (Carcinomatosis) 01/2020 - 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Disease Progression 01/2021
1	Inflammation (Inflammations) 01/2020
1	Embryonal Rhabdomyosarcoma 01/2019
1	Alveolar Rhabdomyosarcoma 01/2019
1	Residual Neoplasm 01/2019
1	Triple Negative Breast Neoplasms 08/2017
1	Inflammatory Breast Neoplasms 08/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Pericardial Effusion 01/2016
1	Pericarditis 01/2016
1	Hodgkin Disease (Hodgkin's Disease) 01/2016
1	Obesity 06/2004
1	Leukemia 07/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2003
1	Crohn Disease (Crohn's Disease) 07/2003

Drug/Important Bio-Agent (IBA)

11	entinostat (MS 275)IBA 01/2020 - 11/2009
8	Histone Deacetylase InhibitorsIBA 01/2020 - 11/2009
3	Pharmaceutical PreparationsIBA 08/2017 - 07/2003
3	Protein Isoforms (Isoforms)IBA 01/2016 - 11/2009
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
2	Interleukin-15 (Interleukin 15)IBA 01/2020 - 01/2019
2	AntigensIBA 01/2020 - 01/2019
2	CytokinesIBA 01/2020 - 01/2017
2	VaccinesIBA 01/2020 - 01/2019
2	ChemokinesIBA 11/2017 - 01/2017
2	Histone Deacetylases (Histone Deacetylase)IBA 07/2014 - 11/2009
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Granzymes (Granzyme)IBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	ALT-803IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2017
1	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 08/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Drug CombinationsIBA 01/2017
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2016
1	Estrogen ReceptorsIBA 01/2016
1	RetinoidsIBA 01/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2016
1	exemestane (Aromasin)FDA Link 01/2016
1	AntibodiesIBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	Aromatase InhibitorsIBA 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Apoptosis Regulatory ProteinsIBA 07/2014
1	Indicators and Reagents (Reagents)IBA 07/2014
1	Tyrosine Kinase InhibitorsIBA 07/2014
1	Lapatinib (GW572016)FDA Link 07/2014
1	Trastuzumab (Herceptin)FDA Link 07/2014
1	Growth Factor ReceptorsIBA 11/2009
1	CarcinogensIBA 09/2008
1	ERRalpha Estrogen-Related ReceptorIBA 06/2004
1	purineIBA 07/2003
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 07/2003

Therapy/Procedure

7	Therapeutics 01/2021 - 11/2009
2	Immunotherapy 01/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2019